Laman UtamaAGIO • NASDAQ
add
Agios Pharmaceuticals Inc
Tutup sebelumnya
$28.00
Julat hari
$27.25 - $28.24
Julat tahun
$22.24 - $46.00
Permodalan pasaran
1.64B USD
Bilangan Purata
1.13J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Mac 2026info | Perubahan T/T |
|---|---|---|
Hasil | 20.75J | 137.75% |
Perbelanjaan pengendalian | — | — |
Pendapatan bersih | — | — |
Margin untung bersih | -477.74 | 53.31% |
Pendapatan bagi setiap syer | -1.69 | -9.03% |
EBITDA | — | — |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Mac 2026info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | — | — |
Jumlah aset | — | — |
Jumlah liabiliti | — | — |
Jumlah ekuiti | — | — |
Syer tertunggak | — | — |
Harga kepada buku | — | — |
Pulangan pada aset | — | — |
Pulangan pada modal | -22.30% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Mac 2026info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | — | — |
Tunai daripada operasi | — | — |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | — | — |
Perubahan bersih dalam tunai | — | — |
Aliran tunai bebas | — | — |
Perihal
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Diasaskan
2008
Tapak web
Pekerja
540
